Sort
21,281 grants matching “influenza”
Novel Chimeric Env Glycoproteins for AIDS Vaccines
$229,500Emory University · R21 · FY2005 · AI
RNA viruses of pandemic potential - viral infectivity
$229,500Emily A. Bruce · University Of Vermont & St Agric College · P20 · FY2023 · GM
Novel Chimeric Env Glycoproteins for AIDS Vaccines
$229,500Emory University · R21 · FY2004 · AI
Viral Manipulation of Myeloid Cell Function
$229,500Christopher Norbury · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2013 · AI
Recent thyme emigrants mitigate viral pulmonary pneumonia
$229,500Derek A Pociask · Tulane University Of Louisiana · R21 · FY2024 · AI
Immunostimulatory single cycle SIV Vaccines incorporating TRAF-mediated molecular
$229,500Geoffrey William Stone · University Of Miami School Of Medicine · R21 · FY2008 · AI
Targeted-delivery of small interference RNA against anthrax
$229,500Mingtao Zeng · Texas Tech University Health Scis Center · R21 · FY2016 · AI
Clinical Phenotyping and Human Core
$229,472Richard G Wunderink · Northwestern University At Chicago · P01 · FY2024 · HL
Development of aerosol fluorescence spectrometer for measuring multiple physicochemical properties of respiratory and drug particles in situ
$229,454Paul Ohno · Auburn University At Auburn · R21 · FY2024 · GM
Norovirus P Particle, A Multifunctional Platform For Vaccine Development
$229,438Ming Tan · Cincinnati Childrens Hosp Med Ctr · R21 · FY2011 · AI
DEVELOPING SUSTAINABLE INFLUENZA SURVEILLANCE NETWORKS AND RESPONSE TO AVIAN AND
$229,357Birjees Mazher Kazi · National Institute Of Health · U51 · FY2011 · IP
NOVEL REVERSE ADJUVANT FOR VACCINE ENHANCEMENT
$229,109Ian Nicholas Crispe · Seattle Biomedical Research Institute · R21 · FY2009 · AI
RESPIRATORY VIRUS ION CHANNELS
$228,983Northwestern University · R01 · FY2000 · AI
Eliciting mucosal immunity in non-human primates
$228,926Roger Legrand · Baylor Research Institute · U19 · FY2012 · AI
Creating high-resolution, epitope-focused vaccines
$228,915Peter S Kim · Stanford University · DP1 · FY2023 · AI
Targeting SARS-CoV-2 induced lung immunopathology using novel genetic mouse models
$228,911Alexei V Tumanov · University Of Texas Hlth Science Center · R21 · FY2022 · AI
Protein Core
$228,881Gerard Zurawski · Baylor Research Institute · U19 · FY2012 · AI
RELM Peptides Alter Lung Defense
$228,875Thomas R Korfhagen · Cincinnati Childrens Hosp Med Ctr · R21 · FY2010 · AI
Integrin regulation of memory CD8 T cells
$228,875Yoji Shimizu · University Of Minnesota · R21 · FY2017 · AI
Bioinformatics Core: Core C
$228,855Rafick-Pierre Sekaly · Drexel University · U19 · FY2020 · AI
Synergizing neutralization and non-neutralization antibody targets at the HIV/SIV viral spike apex
$228,825Timothy J Cardozo · New York University School Of Medicine · R21 · FY2024 · AI
Core 3: Single-Cell Core
$228,825Ivelin Georgiev · Vanderbilt University Medical Center · U19 · FY2023 · AI
Immune phenotyping of responses to influenza virus vaccination and infection
$228,824Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
Optimization of AO drugs 45, 51 & 53
$228,761Eric P Hoffman · Children'S Research Institute · P50 · FY2015 · AR
Autonomic dysreflexia and SCI immune suppression
$228,750Phillip G Popovich · Ohio State University · R21 · FY2009 · NS